181 related articles for article (PubMed ID: 38753434)
1. Proteomic alterations in patients with atopic dermatitis.
Obi A; Rothenberg-Lausell C; Levit S; Del Duca E; Guttman-Yassky E
Expert Rev Proteomics; 2024 May; ():1-11. PubMed ID: 38753434
[TBL] [Abstract][Full Text] [Related]
2. Proteomic signatures of inflammatory skin diseases: a focus on atopic dermatitis.
Mikhaylov D; Del Duca E; Guttman-Yassky E
Expert Rev Proteomics; 2021 May; 18(5):345-361. PubMed ID: 34033497
[No Abstract] [Full Text] [Related]
3. The IL-4, IL-13 and IL-31 pathways in atopic dermatitis.
Dubin C; Del Duca E; Guttman-Yassky E
Expert Rev Clin Immunol; 2021 Aug; 17(8):835-852. PubMed ID: 34106037
[No Abstract] [Full Text] [Related]
4. Atopic dermatitis stratification: current and future perspective on skin and blood transcriptomic and proteomic profiling.
Hawkins K; David E; Glickman JW; Del Duca E; Guttman-Yassky E; Krueger JG
Expert Rev Clin Immunol; 2024 Mar; ():1-6. PubMed ID: 38436065
[TBL] [Abstract][Full Text] [Related]
5. The proteomic skin profile of moderate-to-severe atopic dermatitis patients shows an inflammatory signature.
Pavel AB; Zhou L; Diaz A; Ungar B; Dan J; He H; Estrada YD; Xu H; Fernandes M; Renert-Yuval Y; Krueger JG; Guttman-Yassky E
J Am Acad Dermatol; 2020 Mar; 82(3):690-699. PubMed ID: 31669080
[TBL] [Abstract][Full Text] [Related]
6. Considerations for managing elderly patients with atopic dermatitis.
Napolitano M; Potestio L; Nocerino M; Patruno C
Expert Rev Clin Immunol; 2024 May; 20(5):501-511. PubMed ID: 38193289
[TBL] [Abstract][Full Text] [Related]
7. Managing the Skin Microbiome as a New Bacteriotherapy for Inflammatory Atopic Dermatitis.
Dewi DAR; Perdiyana A; Wiliantari NM; Nadhira F; Arkania N; Salsabila CA; Allun CV; Allatib A; Dewantara K
Cureus; 2023 Nov; 15(11):e48803. PubMed ID: 38024036
[TBL] [Abstract][Full Text] [Related]
8. Tape-Strip Proteomic Profiling of Atopic Dermatitis on Dupilumab Identifies Minimally Invasive Biomarkers.
He H; Olesen CM; Pavel AB; Clausen ML; Wu J; Estrada Y; Zhang N; Agner T; Guttman-Yassky E
Front Immunol; 2020; 11():1768. PubMed ID: 32849633
[TBL] [Abstract][Full Text] [Related]
9. The translational revolution in atopic dermatitis: the paradigm shift from pathogenesis to treatment.
Facheris P; Jeffery J; Del Duca E; Guttman-Yassky E
Cell Mol Immunol; 2023 May; 20(5):448-474. PubMed ID: 36928371
[TBL] [Abstract][Full Text] [Related]
10. Atopic dermatitis: a review of evolving targeted therapies.
Kalamaha K; Reis E; Newton S; Roche C; Julson J; Fernandes H; Rodrigues J
Expert Rev Clin Immunol; 2019 Mar; 15(3):275-288. PubMed ID: 30577713
[TBL] [Abstract][Full Text] [Related]
11. Symbiotic microorganisms: prospects for treating atopic dermatitis.
Chai R; Tai Z; Zhu Y; Chai C; Chen Z; Zhu Q
Expert Opin Biol Ther; 2022 Jul; 22(7):911-927. PubMed ID: 35695265
[TBL] [Abstract][Full Text] [Related]
12. Single-cell transcriptomics combined with interstitial fluid proteomics defines cell type-specific immune regulation in atopic dermatitis.
Rojahn TB; Vorstandlechner V; Krausgruber T; Bauer WM; Alkon N; Bangert C; Thaler FM; Sadeghyar F; Fortelny N; Gernedl V; Rindler K; Elbe-Bürger A; Bock C; Mildner M; Brunner PM
J Allergy Clin Immunol; 2020 Nov; 146(5):1056-1069. PubMed ID: 32344053
[TBL] [Abstract][Full Text] [Related]
13. Transcriptional control and transcriptomic analysis of lipid metabolism in skin barrier formation and atopic dermatitis (AD).
Bhattacharya N; Ganguli-Indra G; Indra AK
Expert Rev Proteomics; 2019 Aug; 16(8):627-645. PubMed ID: 31322970
[No Abstract] [Full Text] [Related]
14. Towards personalized treatment in atopic dermatitis.
van der Schaft J; Thijs JL; Garritsen FM; Balak D; de Bruin-Weller MS
Expert Opin Biol Ther; 2019 May; 19(5):469-476. PubMed ID: 30768375
[TBL] [Abstract][Full Text] [Related]
15. Shedding light on key pharmacological knowledge and strategies for pediatric atopic dermatitis.
Moreno A; Renert-Yuval Y; Guttman-Yassky E
Expert Rev Clin Pharmacol; 2023 Feb; 16(2):119-131. PubMed ID: 36705936
[TBL] [Abstract][Full Text] [Related]
16. Biomarkers in atopic dermatitis.
Bakker D; de Bruin-Weller M; Drylewicz J; van Wijk F; Thijs J
J Allergy Clin Immunol; 2023 May; 151(5):1163-1168. PubMed ID: 36792449
[TBL] [Abstract][Full Text] [Related]
17. Atopic Dermatitis Endotypes Based on Allergen Sensitization, Reactivity to Staphylococcus aureus Antigens, and Underlying Systemic Inflammation.
Leonard A; Wang J; Yu L; Liu H; Estrada Y; Greenlees L; McPhee R; Ruzin A; Guttman-Yassky E; Howell MD
J Allergy Clin Immunol Pract; 2020 Jan; 8(1):236-247.e3. PubMed ID: 31430591
[TBL] [Abstract][Full Text] [Related]
18. Biological medication in atopic dermatitis.
Fölster-Holst R; Torrelo A; Das K; Murrell DF; Patil A; Rahmat Pour Rokni G; Grabbe S; Staubach P; Sohn A; Goldust M
Expert Opin Biol Ther; 2022 May; 22(5):643-649. PubMed ID: 34991429
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of biologics in atopic dermatitis.
Wu J; Guttman-Yassky E
Expert Opin Biol Ther; 2020 May; 20(5):525-538. PubMed ID: 32003247
[No Abstract] [Full Text] [Related]
20. Co-occurrence network analysis reveals the alterations of the skin microbiome and metabolome in adults with mild to moderate atopic dermatitis.
P Gomes PW; Mannochio-Russo H; Mao J; Zhao HN; Ancira J; Tipton CD; Dorrestein PC; Li M
mSystems; 2024 Mar; 9(3):e0111923. PubMed ID: 38319107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
